{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:46:58Z","timestamp":1777139218716,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10792-020-01472-8","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T15:04:54Z","timestamp":1594047894000},"page":"2875-2887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-4099","authenticated-orcid":false,"given":"Hind M.","family":"Alkatan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad A.","family":"Al-Dahmash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh A.","family":"Almesfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal S.","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azza M. Y.","family":"Maktabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/oxfordjournals.bmb.a011577","volume":"52","author":"CA Stiller","year":"1996","unstructured":"Stiller CA, Parkin DM (1996) Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 52:682\u2013703","journal-title":"Br Med Bull"},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nature10275","volume":"476","author":"AH Berger","year":"2011","unstructured":"Berger AH, Knudson AG, Pandolfi PP (2011) A continuum model for tumour suppression. Nature 476:163\u2013169","journal-title":"Nature"},{"issue":"2","key":"1472_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3928\/01913913-20190128-02","volume":"56","author":"R Darwich","year":"2019","unstructured":"Darwich R, Ghazawi FM, Rahme E et al (2019) Retinoblastoma incidence trends in Canada: a national comprehensive population-based study. J Pediatr Ophthalmol Strabismus 56(2):124\u2013130. https:\/\/doi.org\/10.3928\/01913913-20190128-02","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"5829284","DOI":"10.1155\/2019\/5829284","volume":"2019","author":"JJ Yahaya","year":"2019","unstructured":"Yahaya JJ, Rugwizangoga B, Mremi A, Munema A (2019) Clinicopathological findings of retinoblastoma: a 10-year experience from a tertiary hospital in Kampala, Uganda. J Ophthalmol 2019:5829284. https:\/\/doi.org\/10.1155\/2019\/5829284eCollection 2019","journal-title":"J Ophthalmol"},{"issue":"11","key":"1472_CR5","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jamaophthalmol.2015.3108","volume":"133","author":"DH Abramson","year":"2015","unstructured":"Abramson DH, Shields CL, Munier FL, Chantada GL (2015) Treatment of retinoblastoma in 2015: agreement and disagreement. JAMA Ophthalmol 133(11):1341\u20131347. https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.3108","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"1472_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archopht.116.7.887","volume":"116","author":"NE Bechrakis","year":"1998","unstructured":"Bechrakis NE, Bornfeld N, Schueler A, Coupland SE, Henze G, Foerster MH (1998) Clinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 116(7):887\u2013893. https:\/\/doi.org\/10.1001\/archopht.116.7.887","journal-title":"Arch Ophthalmol"},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1136\/bjophthalmol-2014-306364","volume":"99","author":"RC Brennan","year":"2015","unstructured":"Brennan RC, Qaddoumi I, Billups CA, Free TL, Haik BG, Rodriguez-Galindo C, Wilson MW (2015) Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma. Br J Ophthalmol 99:1366\u20131371","journal-title":"Br J Ophthalmol"},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/bjophthalmol-2017-310624","volume":"102","author":"ID Fabian","year":"2018","unstructured":"Fabian ID, Stacey AW, Johnson KC, Chowdhury T, Duncan C, Reddy MA, Sagoo MS (2018) Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye. Br J Ophthalmol 102:265\u2013271","journal-title":"Br J Ophthalmol"},{"key":"1472_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01342-3","author":"HM Alkatan","year":"2020","unstructured":"Alkatan HM, AlQahtani FS, Maktabi AMY (2020) Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th Edition of the American Joint Commission on Cancer (AJCC). Int Ophthalmol. https:\/\/doi.org\/10.1007\/s10792-020-01342-3","journal-title":"Int Ophthalmol"},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41433-019-0409-z","volume":"33","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Mittal P, Mohan S, Chattannavar G, Jajapuram SD, Mohamed A, Palkonda VAR (2019) Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients. Eye 33:1297\u20131304. https:\/\/doi.org\/10.1038\/s41433-019-0409-z","journal-title":"Eye"},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1001\/archopht.1996.01100140521001","volume":"114","author":"BL Gallie","year":"1996","unstructured":"Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chan HS (1996) Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114:1321\u20131328","journal-title":"Arch Ophthalmol"},{"key":"1472_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/archopht.1996.01100140548005","volume":"114","author":"AL Murphree","year":"1996","unstructured":"Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ (1996) Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348\u20131356","journal-title":"Arch Ophthalmol"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/archopht.1996.01100140530002","volume":"114","author":"CL Shields","year":"1996","unstructured":"Shields CL, DePotter P, Himelstein BP, Meadows AT, Maris JM (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330\u20131338","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1472_CR14","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.12816\/ejhm.2018.18581","volume":"73","author":"M Wahdan","year":"2018","unstructured":"Wahdan M, Shaleel A, El Zomor H, El Baz H (2018) Outcome of unilateral intraocular retinoblastoma. Egypt J Hospital Med 73(9):7412\u20137417. https:\/\/doi.org\/10.12816\/ejhm.2018.18581","journal-title":"Egypt J Hospital Med"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","volume":"1","author":"M Jain","year":"2019","unstructured":"Jain M, Rojanaporn D, Chawla B, Sundar G, Gopal L, Khetan V (2019) Retinoblastoma in Asia. Eye (Lond) 1:87\u201396. https:\/\/doi.org\/10.1038\/s41433-018-0244-7","journal-title":"Eye (Lond)"},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bjophthalmol-2015-306672","volume":"100","author":"B Chawla","year":"2015","unstructured":"Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM (2015) Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol 100:172\u2013178","journal-title":"Br J Ophthalmol"},{"key":"1472_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000477408","volume":"4","author":"U Singh","year":"2018","unstructured":"Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R (2018) Retinoblastoma: a sixteen-year review of the presentation, treatment, and outcome from a tertiary care institute in Northern India. Ocul Oncol Pathol 4:23\u201332","journal-title":"Ocul Oncol Pathol"},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3109\/13816810.2013.867450","volume":"36","author":"PK Shah","year":"2015","unstructured":"Shah PK, Narendran V, Kalpana N (2015) Outcomes of intra-and extraocular retinoblastomas from a single institute in South India. Ophthalmic Genet 36:248\u2013250","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"1472_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ophtha.2017.01.048","volume":"124","author":"ID Fabian","year":"2017","unstructured":"Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA, Sagoo MS (2017) High-risk histopathology features in primary and secondary enucleated international intraocular retinoblastoma classification group D eyes. Ophthalmology 124(6):851\u2013858. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.048","journal-title":"Ophthalmology"},{"issue":"8","key":"1472_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/archopht.121.8.1125","volume":"121","author":"H Demirci","year":"2003","unstructured":"Demirci H, Eagle RC, Shields CL, Shields JA (2003) Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol 121(8):1125\u20131131. https:\/\/doi.org\/10.1001\/archopht.121.8.1125","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"1472_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3980\/j.issn.2222-3959.2013.03.26","volume":"6","author":"C Luo","year":"2013","unstructured":"Luo C, Deng YP (2013) Retinoblastoma: concerning its initiation and treatment. Int J Ophthalmol 6(3):397\u2013401. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2013.03.26","journal-title":"Int J Ophthalmol"},{"issue":"9","key":"1472_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.4103\/0301-4738.119424","volume":"61","author":"B Chawla","year":"2013","unstructured":"Chawla B, Jain A, Azad R (2013) Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol 61(9):479\u2013485. https:\/\/doi.org\/10.4103\/0301-4738.119424","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"1472_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/bjo.87.1.90","volume":"87","author":"AO Schueler","year":"2003","unstructured":"Schueler AO, Jurklies C, Heimann H, Wieland R, Havers W, Bornfeld N (2003) Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 87(1):90\u201395. https:\/\/doi.org\/10.1136\/bjo.87.1.90","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1472_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.sjopt.2013.07.009","volume":"27","author":"A Alkofide","year":"2013","unstructured":"Alkofide A, Ayas M, Khafagah Y, Rawashde A, Anas M, Barri M, Siddiqui K, AlMesfer S, Alkatan H (2013) Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience. Saudi J Ophthalmol 27(3):193\u2013196. https:\/\/doi.org\/10.1016\/j.sjopt.2013.07.009","journal-title":"Saudi J Ophthalmol"},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1200\/JCO.2010.32.5332","volume":"29","author":"J Zhao","year":"2011","unstructured":"Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL (2011) Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis. J Clin Oncol 29:845\u2013851","journal-title":"J Clin Oncol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-020-01472-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T23:23:36Z","timestamp":1625527416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-020-01472-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01472-8","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was prepared in accordance with the ethical standards of the human ethics committee at KKESH and expedited approval as a retrospective study from the HEC\/IRB of the Research department in accordance with the Helsinki Declaration (Research project #RP 1941-R). A general informed written consent was taken from the guardians of all cases which includes permission for anonymous use of data for the purpose of publication. The authors have no conflict of interest or financial disclosures in relation to this work. This work did not receive funding from any of the institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}